NICOLE MCLEMORE: Open Payments
NPI 1063131316 · COVINGTON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 15 payments from 8 companies in 2025. Trend: 2023 $49 · 2024 $464 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $117 |
| Otsuka America Pharmaceutical, Inc. | 2 | $92 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $82 |
| Axsome Therapeutics, Inc. | 1 | $64 |
| Vanda Pharmaceuticals Inc. | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 1 | $29 |
| Alkermes, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: VRAYLAR, REXULTI, CAPLYTA, Auvelity, HETLIOZ, UZEDY, ARISTADA, TRINTELLIX.
Industry payments across TN — which companies pay providers there.
